pharmaceutical company’s pricing for a non-proprietary drug

pharmaceutical company’s pricing for a non-proprietary drug

Module 5 Discussion – Price and Distribution Question 1.

Explain how a pharmaceutical company’s pricing for a non-proprietary drug might change if the objective was: (a) profitability, (b) sales volume, or (c) market share.

Please respond to one of your peers’ responses (please refrain from answering “I agree”). Please respond in detail to your peers why you agree or disagree with their answer.

Module 5 Discussion – Price and Distribution Question 2

List and discuss at least five [5] of the pricing strategies covered in the textbook.

Please respond to one of your peers’ responses (please refrain from answering “I agree”). Please respond in detail to your peers why you agree or disagree with their answer.

Module 5 Discussion – Price and Distribution Question 3

In a recent contract negotiation session between a group of physicians and a managed care health plan, the parties disagreed about the level of reimbursement that the physicians would receive for treating subscribers. The physician group is the largest such organization in the community and represents 75 percent of all primary care providers in the area. What sources of power does this group wield in negotiating a managed care contract?